Previous images show the 2D dose maps obtained with the GEM detector in 64 seconds. On the right there is the map for a 2,4 x 2,4 cm X-rays irradiation field, on the left the one for a 4,0 x 4,0 cm Xrays irradiation field. Conclusions: Our detector could represent significant improvement compared to measurement systems used until today. The results confirm its potentialities especially in terms of spatial resolution, acquisition time and linearity. Purpose/Objective: Two-dimensional (2D) array detector has finite resolution due to its detector size and spacing. Dosimetric verification of small targets planned with IMRT is difficult because of the limited resolution as only a limited number of pixels handling the fluence. In addition, the overall inaccuracy due to the interpolation of signals will be higher. However, if the small field IMRT is verified at extended source to surface distance (SSD), fluence can be handled by the large area of the array and hence the more number of detectors due to inverse square law. Therefore, the purpose of the present study is to evaluate the response of 2D-detector array at extended SSDs for pretreatment verification of small targets. Materials and Methods: Four previously treated patients were studied. In planning CT slices, planning target volume (PTV) and organ at risk (OAR) were contoured. IMRT (sliding window) plans were generated in Eclipse (Varian Medical Systems, Palo Alto, CA, USA) treatment planning system (TPS) for Varian CL2300C/D linear accelerator using 5-7 fields of 6MV photon beam. For each patient, four verification plans were generated at 95cm, 100cm, 105cm and 110cm SSD by keeping I'matriXX at 5cm depth. The planned fluence was then transferred to previously scanned I'matriXX (IBADosimetry, Scanditronix Wellhofer, Germany) and solid water slab assembly and doses were calculated. The dose planes measured with I'matriXX were compared with TPS calculated dose planes at corresponding SSD in OmniPro-IMRT software using 2D gamma (γ) index analysis. For gamma index analysis, 3% dose difference and 3mm distance to agreement criteria (3%/3mm) was used. Three parameters i.e. gamma maximum (γ max. ), gamma average (γ avg. )and percentage of pixels passing gamma value up to 1 (γ % ≤1) were noted.
Purpose/Objective: Two-dimensional (2D) array detector has finite resolution due to its detector size and spacing. Dosimetric verification of small targets planned with IMRT is difficult because of the limited resolution as only a limited number of pixels handling the fluence. In addition, the overall inaccuracy due to the interpolation of signals will be higher. However, if the small field IMRT is verified at extended source to surface distance (SSD), fluence can be handled by the large area of the array and hence the more number of detectors due to inverse square law. Therefore, the purpose of the present study is to evaluate the response of 2D-detector array at extended SSDs for pretreatment verification of small targets. Materials and Methods: Four previously treated patients were studied. In planning CT slices, planning target volume (PTV) and organ at risk (OAR) were contoured. IMRT (sliding window) plans were generated in Eclipse (Varian Medical Systems, Palo Alto, CA, USA) treatment planning system (TPS) for Varian CL2300C/D linear accelerator using 5-7 fields of 6MV photon beam. For each patient, four verification plans were generated at 95cm, 100cm, 105cm and 110cm SSD by keeping I'matriXX at 5cm depth. The planned fluence was then transferred to previously scanned I'matriXX (IBADosimetry, Scanditronix Wellhofer, Germany) and solid water slab assembly and doses were calculated. The dose planes measured with I'matriXX were compared with TPS calculated dose planes at corresponding SSD in OmniPro-IMRT software using 2D gamma (γ) index analysis. For gamma index analysis, 3% dose difference and 3mm distance to agreement criteria (3%/3mm) was used. Three parameters i.e. gamma maximum (γ max. ), gamma average (γ avg. )and percentage of pixels passing gamma value up to 1 (γ % ≤1) were noted.
Results:
Results are summarized in table-1. After modelling, we performed several verifications: 1) Accuracy of monitor unit calculations for several SSD and depths. Manual calculation of monitor units performed with measured data shows a maximum difference of 1.3%. 2) Isocentre verification.We used a radiochromic film (Gafchromic EBT2) placed in the stereotactic localizer with a pin to locate isocentre. After a CT scan was made, pin delineated and used like isocentre to deliver the treatment. Isocentre localization was less than 0.5mm. (Fig1) .
3) For dose verification we scanned an anthropomorphic Alderson Rando phantom head (Fig.2) with a MOSFET detector placed inside. We localized the CT scan using iPLan, marked the isocentre at the MOSFET and delivered treatment. The dose agreement was for the 10-mm cone, lesser than 5% (MOSFET uncertainty: 3%). For smaller cones, the dose gradient makes very difficult the positioning of the MOSFET, hence difference between planned dose and measured dose increases. 4) Verification with gafchromic EBT2. A film wasplaced at depth of 15 mm in a water phantom and an arc of 120° was delivered. We compared measured datawith TPS calculation using OmniPro ® (IBA). A good agreement is showed for inplane and crossplane comparisons. (Fig3) Conclusions: Due to the difficulty for measuring small fields we performed several verifications using different measurement methods to commission the modelling of Brainlab cones for trigeminal neuralgia in iPlan. The most accurate and reliable method for measuring relative dose is Gafchromics films, because it have the best resolution. Diodes and MOSFET can be used for output factor measurements, but corrections must be taken into account. Results are consistent and the first clinical results indicate a favourable evolution.
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